Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
QRX003
product3 mentionslast seen Oct 20, 2026
Investigational topical serine protease inhibitor lotion for rare skin diseases.
Relationships 11
- Quoin Pharmaceuticals Ltd.developsQRX00399% confidence3 sources
- QRX003applies toNetherton Syndrome treatment99% confidence3 sources
- QRX003conforms toFast Track Designation99% confidence2 sources
- QRX003applies toPeeling Skin Syndrome treatment99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesQRX00396% confidence1 source
- QRX003conforms toOrphan Drug designation95% confidence1 source
- QRX003conforms toOrphan Drug Designation Europe95% confidence1 source
- European Medicines AgencyapprovesQRX00395% confidence1 source
- QRX003conforms toRare Pediatric Disease designation93% confidence1 source
- U.S. Food and Drug AdministrationapprovesQRX00392% confidence1 source
- QRX003applies torare and orphan skin diseases90% confidence1 source
Relationship
European Medicines AgencyapprovesQRX003
95% confidence1 supporting mentionsfrom Oct 14, 2026
Either name opens that entity’s relationships.
Sources 1